Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Menopause Drugs from Depomed, Hisamitsu Offer Benefits
Bloomberg
Thursday, February 28, 2013 - 11:36am
tags:
Depomed, Hisamitsu, menopause, hot flashes, gabapentin, paroxetine mesylate
Incyte's Jakafi Is Likely A $1 Billion Drug
Seeking Alpha
Thursday, February 28, 2013 - 11:35am
tags:
Jakafi, Incyte, myelofibrosis
AVEO to meet with FDA about tivozanib
Bizjournals.com
Thursday, February 28, 2013 - 11:33am
tags:
FDA, Aveo, tivozanib, kidney cancer
3 Bio-Pharmaceuticals You Can't Ignore
Motley Fool
Thursday, February 28, 2013 - 11:32am
tags:
Amarin, Vivus, Arena Pharmaceuticals
A Drug That's Ready to Lose
Motley Fool
Thursday, February 28, 2013 - 11:30am
tags:
Belviq, Arena Pharmaceuticals, Vivus, Eisai
It's Now Time For Vivus Investors To Watch Arena Numbers
Seeking Alpha
Thursday, February 28, 2013 - 11:28am
tags:
Vivus, Arena
Medivation falls after analyst says Xtandi must overcome obstacles
The Fly on the Wall
Thursday, February 28, 2013 - 11:27am
tags:
Medivation, Xtandi, prostate cancer
Why Expect More Price Swings From These 4 Biotechs
TheStreet.com
Thursday, February 28, 2013 - 11:26am
tags:
Dendreon, Keryx, Oncolytics, Vivus
Valeant Earnings Seen Rising As Firm Digests Medicis
Investors.com
Thursday, February 28, 2013 - 10:55am
tags:
earnings, Valeant Pharmaceuticals, Medicis
Pernix Therapeutics Receives FDA Approvals
Yahoo
Thursday, February 28, 2013 - 10:54am
tags:
FDA, Pernix, Mefenamic Acid, Vituz
Bayer Sees 2013 Sales Growth on Drugs, Crop Chemicals
Bloomberg
Thursday, February 28, 2013 - 10:52am
tags:
earnings, Bayer
Mylan to buy injectable drugs unit of India's Strides for $1.6 bln
Reuters
Thursday, February 28, 2013 - 10:50am
tags:
Mylan, M&A, India, Strides Arcolab, injectables, Agila
Niacin-statin combination tied to skin, muscle side effects
Reuters
Thursday, February 28, 2013 - 10:49am
tags:
statins, niacin, Merck, Tredaptive
Why Sarepta Therapeutics Shares Shot Higher
Motley Fool
Wednesday, February 27, 2013 - 5:25pm
tags:
Sarepta, Duchenne Muscular Dystrophy, eteplirsen
This FDA Approval Is Actually a Big Deal
Motley Fool
Wednesday, February 27, 2013 - 12:40pm
tags:
Kadcyla, Roche, Immunogen
Solid Where It Matters: Questcor To Climb On Strong Quarter And Dividend Raise
Seeking Alpha
Wednesday, February 27, 2013 - 12:30pm
tags:
earnings, Questcor
ViroPharma Earnings: Here’s Why Investors are Not Happy Now
Wall St. Cheat Sheet
Wednesday, February 27, 2013 - 12:29pm
tags:
earnings, ViroPharma
Is Takeda Interested In Aastrom Bio?
Seeking Alpha
Wednesday, February 27, 2013 - 12:28pm
tags:
Takeda, Aastrom Biosciences, M&A
US Supreme Court rules against Amgen in class action
Reuters
Wednesday, February 27, 2013 - 12:26pm
tags:
Amgen, Supreme Court
The Sum Of JNJ's Parts: Medical Devices
Motley Fool
Wednesday, February 27, 2013 - 12:17pm
tags:
JNJ, devices

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.